Erik Nerpin

Erik Nerpin discloses dealings in Diamyd Medical Aktiebolag to Finansinspektionen. The record holds 9 filings, for trades running from 24 May 2017 to 30 September 2024.

None of the filings is a plain purchase or sale on the open market; they cover grants, option exercises and other movements. Compensation-driven entries like these are tracked, but they say little about how insiders judge the share price.

On 2 October 2024 came the latest disclosure, a transaction in Diamyd Medical Aktiebolag. The median gap between a trade and its publication by Finansinspektionen is 1 day. For comparison, MAR article 19 gives managers three business days to notify a trade. This summary is built from Finansinspektionen disclosures alone and does not predict where the share price will go.